Form 4 for INKT MiNK Therapeutics, Inc.
Accepted 2023-05-03 00:00:00 ET · period of report 2023-05-01 · accession 0000899243-23-012119 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-03 | 2023-05-01 | INKT | AGENUS INC | 10% | J - Other | $0.00 | -4.99M | 21.34M | -19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-01 | J | D | 4,988,273 | $0.00 | 21,344,685 | D | — | — |